Product Information
SIROLIMUS 1 MG/ML SOLUTION is a generic product labeled by Apotex Corp., priced at $4.3903 per ML under NDC 60505619702. Its NADAC has been published 228 times since Feb 17, 2021.
FDA first approved this application on Oct 22, 2019. Its Orange Book therapeutic-equivalence code is AA.
Strength
1 mg/mL
Manufacturer
Apotex Corp.NDC
60505619702
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SIROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA211406FDA Approved
10/22/2019
TE Code
AA
On Market Since
5/20/2020
Pharmacological Classes
Price Statistics
The NADAC for SIROLIMUS 1 MG/ML SOLUTION has been published 228 times since Feb 17, 2021, and over the history we have for it it has declined 73.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.3903 per ML |
|---|---|
| All-time high | $16.6782 (Feb 16, 2022) |
| All-time low | $4.3903 (Sep 23, 2026) |
| 52-week high | $5.2539 |
| 52-week low | $4.3903 |
| Median price | $7.1197 |
| Average price | $8.7488 |
| Largest weekly change | -48.4% (Feb 23, 2022) |
| Weeks tracked | 228 |
| Tracking since | Feb 17, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the SIROLIMUS market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
SIROLIMUS market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Kinase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SIROLIMUS 1 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for SIROLIMUS 1 MG/ML SOLUTION, manufactured by Apotex Corp., is $4.3903 per ML (NDC 60505619702), effective Sep 30, 2026.
How has the price of SIROLIMUS 1 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for SIROLIMUS 1 MG/ML SOLUTION has declined 73.7%. It has been tracked across 228 weekly CMS publications since Feb 17, 2021.
What are the highest and lowest recorded NADAC prices for SIROLIMUS 1 MG/ML SOLUTION?
Since Feb 17, 2021, the NADAC for SIROLIMUS 1 MG/ML SOLUTION has ranged from a low of $4.3903 (Sep 23, 2026) to a high of $16.6782 (Feb 16, 2022), with a median of $7.1197 per ML.
Are there cheaper alternatives to SIROLIMUS 1 MG/ML SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of SIROLIMUS 1 MG/ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SIROLIMUS 1 MG/ML SOLUTION?
SIROLIMUS 1 MG/ML SOLUTION (NDC 60505619702) is labeled by Apotex Corp., and CMS classifies it as a generic product.